Biotechnology

Techseriesinsight > Blog > News > Biotechnology

August 4, 2023
PRNewswire
Biotechnology, Press Release

Skanska signs contract with Seagen to build facility in Washington, USA for USD 215 M, about SEK 2.25 billion

Skanska has finalized a contract with Seagen to construct a 25,000 square meter biomanufacturing facility for the global biotechnology company. The facility will include manufacturing, storage, shipping, office, and...

August 3, 2023
PRNewswire
Biotechnology

MANA Develops Novel “Drycell” Microdroplets to Make Handling Single Cell Easier

Scientists at the Research Center for Materials Nanoarchitectonics (MANA) have developed micrometer-sized “liquid marbles” that can encapsulate single to several living cells, thereby aiding single-cell studies. To analyze individual...

August 1, 2023
PRNewswire
Artificial Intelligence, Biotechnology

ILIKOS Consulting Group and Simmunome Announce Strategic Partnership

With the average new drug taking 10 years in clinical development, combined with a $2B+ price tag and 90% failure rate, the clinical research model is no longer sustainable...

July 5, 2023
tsi_admin
Biotechnology

Biocomposites invests in Renovos Biologics – developers of the RENOVITE® nanoclay therapeutic delivery platform

Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft tissue, today announces it has...

June 21, 2023
PRNewswire
Biotechnology

Exact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced separate collaborations with two renowned healthcare organizations at the forefront of cancer research. The...

June 21, 2023
PRNewswire
Artificial Intelligence, Biotechnology

Nuvilab Awarded as 2023 Technology Pioneer by World Economic Forum

Amidst the escalating global concern surrounding food & nutrition insecurity and inequality, a remarkable surge of corporate initiatives has emerged, aiming to combat the prevailing issue of food circularity....

June 19, 2023
PRNewswire
Artificial Intelligence, Biotechnology

Delta4 Identifies a Potential New Therapeutic Option for Focal Segmental Glomerulosclerosis (FSGS) using computational Hyper-C Drug Discovery Platform

Delta4, a pioneering digital drug discovery company specializing in identifying new therapeutic indications for drugs with established safety profiles, has made a promising breakthrough in the search for novel...

June 6, 2023
PRNewswire
Biotechnology

The combination of ISA101b and Libtayo® shows promising results in patients whose head and neck cancer progressed on anti-PD1 therapy

ISA Pharmaceuticals B.V., a clinical-stage biotechnology company developing immunotherapies to treat cancers and serious infectious diseases, presented the first clinical data of the combination of ISA101b (peltopepimut-S) and Regeneron’s anti-PD-1...

May 31, 2023
Business Wire
Biotechnology

New Preclinical Data on AI-Generated Target Identified in BenevolentAI and AstraZeneca Collaboration Presented at ATS 2023

BenevolentAI (Euronext Amsterdam: BAI), a leader that combines cutting-edge Artificial Intelligence (AI) and science to accelerate biopharma discovery and development, announces that AstraZeneca presented new preclinical data on an...

May 22, 2023
PRNewswire
Biotechnology

A.Menarini Diagnostics announces the release of the PRIME MDx platform

A.Menarini Diagnostics S.r.l. is pleased to announce the commercial launch of its PRIME MDx platform: a sample-to-result, all-in-one, fully-automated molecular diagnostics platform for the processing of various testing portfolios through...